2-(2-ethoxyethoxy)acetic acid - CAS 7743-94-4
Catalog: |
BB055196 |
Product Name: |
2-(2-ethoxyethoxy)acetic acid |
CAS: |
7743-94-4 |
Synonyms: |
(2-Ethoxyethoxy)acetic acid; 2-(2-ethoxyethoxy)acetic acid; beta-ethoxyethoxyacetic acid; 2-(2-ethoxyethoxy)aceticacid; Acetic acid, (2-ethoxyethoxy)- |
IUPAC Name: | 2-(2-ethoxyethoxy)acetic acid |
Description: | 2-(2-ethoxyethoxy)acetic acid (cas# 7743-94-4) is a useful research chemical. |
Molecular Weight: | 148.15 |
Molecular Formula: | C6H12O4 |
Canonical SMILES: | CCOCCOCC(=O)O |
InChI: | InChI=1S/C6H12O4/c1-2-9-3-4-10-5-6(7)8/h2-5H2,1H3,(H,7,8) |
InChI Key: | LVLQKFRSMSHJIE-UHFFFAOYSA-N |
Solubility: | Chloroform, Ethyl Acetate (Slightly) |
Appearance: | Colourless Oil |
Storage: | -20°C, Inert atmosphere |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P264, P264+P265, P273, P280, P302+P352, P305+P354+P338, P317, P321, P332+P317, P362+P364, P391, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021254979-A1 | Chemokine-selective cxcr4 ectodomain-derived (poly)peptide | 20200616 |
WO-2021221084-A1 | Blocked isocyanate composition, heat-curable resin composition, cured product, production method therefor, amidate compound, and catalyst for dissociation of blocking agent for blocked isocyanates | 20200430 |
WO-2021221090-A1 | Blocked polyisocyanate composition, heat-curable resin composition, cured product, and production method therefor | 20200430 |
WO-2021200783-A1 | Amidate compound, production method therefor, blocking-agent dissociation catalyst, and thermally curable resin composition | 20200330 |
WO-2021177267-A1 | Prevention or treatment of aneurysms using mir-33b inhibitor | 20200302 |
WO-2021157587-A1 | Method for producing carboxylate compound and method for producing amidate compound | 20200203 |
TW-202136217-A | Method for producing carboxylate compound and method for producing amide salt compound | 20200203 |
US-2021238472-A1 | Methods for clay swelling inhibition using gemini surfactants containing a saturated linker | 20200130 |
US-2021222052-A1 | Gemini surfactants containing an arylene linker for clay swelling inhibition | 20200121 |
US-2021189222-A1 | Gemini surfactants containing an unsaturated linker for clay swelling inhibition | 20191218 |
PMID | Publication Date | Title | Journal |
21705463 | 20120101 | Urinary biomarkers of exposure to glycol ethers and chlorinated solvents during pregnancy: determinants of exposure and comparison with indirect methods of exposure assessment | Occupational and environmental medicine |
20812373 | 20110101 | Peptide vaccine candidates against classical swine fever virus: T cell and neutralizing antibody responses of dendrimers displaying E2 and NS2-3 epitopes | Journal of peptide science : an official publication of the European Peptide Society |
15705492 | 20050328 | Biomonitoring of 2-(2-alkoxyethoxy)ethanols by analysing urinary 2-(2-alkoxyethoxy)acetic acids | Toxicology letters |
Complexity: | 91.7 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 148.07355886 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 148.07355886 |
Rotatable Bond Count: | 6 |
Topological Polar Surface Area: | 55.8Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS